Skip to content

Stenting of Haemodialysis Acces Trial

Stenting of Haemodialysis Acces Re-stenosis Trial (SHARE Trial)

Status
Terminated
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00642083
Acronym
SHARE
Enrollment
20
Registered
2008-03-24
Start date
Unknown
Completion date
2011-08-31
Last updated
2011-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Outflow Stenosis

Keywords

outflow stenosis, stentgraft

Brief summary

The purpose of this study is to demonstrate the efficacy of a PTFE covered stent-graft in the prevention of outflow re-stenosis in loop fistula in a prospective trial.

Interventions

DEVICEViabahn stent-graft

The viabahn stent-graft is a combined ePTFE-Nitinol self-expanding stent-graft preloaded on a catheter-based delivery system. It was originally designed for improving blood flow in patients with symptomatic peripheral arterial disease in superficial femoral artery lesions with reference vessel diameters ranging from 4.8 to 7.5 mm. This device is also increasingly used for the exclusion of popliteal aneurysms. Its flexibility might make the device ideal for the treatment of recurrent outflow stenosis in AV loop-fistula.

Sponsors

W.L.Gore & Associates
CollaboratorINDUSTRY
Rijnstate Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients of 18 years of age * Patients have a life expectancy of at least 2 years * Signed informed consent * Recurrent stenosis at the venous anastomosis or in the draining vein of a loop arterio venous fistula, within 2 cm from the anastomosis.

Exclusion criteria

* Patient unsuitable for administration of contrast agent * Pregnancy * Dementia or altered mental status that would prohibit giving conscious informed consent * Need for adjunctive major surgical or vascular procedures within one month

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026